CURE19h
Cretostimogene Has Durable Response in BCG-Unresponsive Bladder Cancer
Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...
Nasdaq2mon
Nasdaq and BCG Report Reveals How Banks Can Reduce Complexity and Unlock Opportunity
A new report released today, January 22, from Nasdaq and Boston Consulting Group (BCG), suggests that by embracing a systems-based approach powered by modern technologies like artificial ...
UroToday12d
SES AUA 2025: Oncologic Efficacy of Reduced versus Standard-Dose BCG for NMIBC
SESAUA annual meeting featured a bladder cancer session and a presentation by Dr. Meredith Bernhard discussing the oncologic efficacy of reduced versus standard-dose BCG for non muscle invasive ...
The Bakersfield Californian14d
Liberty Global to Present at the NewStreet Research and BCG Future of Connectivity Leaders Conference
Liberty Global (NASDAQ: LBTYA, LBTYB and LBTYK) is a dynamic team of operators and investors generating and delivering shareholder value through the strategic management of three platforms — Liberty ...
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
Updated clinical & translational results: BOND-003 Cohort C- A phase 3, single-arm study of intravesical cretostimogene grenadenorepvec for high-risk BCG-unresponsive non-muscle invasive bladder ...